Clinical Trials Browser

Phase 2/3 × Radiodermatitis × Clear all

NCT07353671 2026-03-25

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

Phase 2/3 Recruiting

Head and Neck Neoplasms, Radiodermatitis

NCT04059809 2021-08-13

Photobiomodulation for Breast Cancer Radiodermatitis

Phase 2/3 Completed

Breast Neoplasms, Radiation Injuries, Radiodermatitis

NCT01246973 2016-03-07

Oral Curcumin for Radiation Dermatitis

Phase 2/3 Completed

686 enrolled 8 charts

Radiodermatitis